News
1h
24/7 Wall St. on MSNThese 2 Dividend Giants Are at 52-Week Lows. Time to Buy?One man's trash may be another man's treasure, but dumpster diving when investing carries risks. You have to wade through a ...
Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...
5h
Barchart on MSNAnalysts Love These 2 Stocks to Buy for Q2With macroeconomic uncertainty swirling, Bank of America analyst Anthony Cassamassino warns that a worst-case scenario could ...
The results exceeded Wall Street targets and pushed the U.S. drugmaker's shares up 11% in premarket trading, while dragging ...
Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...
PARIS – Amid the luxury slowdown, Hermès International showed continued strength with sales in the first quarter up 7 percent ...
Eli Lilly shares slid 8.2% last month thanks to tariff tremors and Medicare’s snub of pricey weight-loss drugs. The company’s ...
The maker of factory robots, electric motors and drives said its operational earnings before interest, tax and amortisation ...
Eli Lilly's Zepbound injection is available to patients for weight loss. Photo: Shelby Knowles/Bloomberg via Getty Images ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results